^

Affiliate

ADROP Election

The 2023 ADROP election for the next Vice-president (President-elect) on the ADROP Executive Committee will be held virtually directly after the ADROP Annual Meeting concludes. Digital ballots will be distributed by email on Saturday, September 30, 2023, to all ADROP member institutions (one ballot per program). If your program has more than one ADROP member, the ballot will be sent to the program director on record. Electronic voting will conclude at 11:59 p.m. Eastern time on Monday, October 16.


2023 ADROP Vice-president Candidate

 

Albert Attia, MD

Senior Associate Consultant, Mayo Clinic Florida

 

Education

  • MD, Vanderbilt University School of Medicine, Nashville, Tennessee, 2007
  • BE, Vanderbilt University, Nashville, Tennessee, 2003

Postgraduate Education

  • Preliminary Year, Mount Sinai Medical Center, Miami Beach, Florida, 2008
  • Residency, Wake Forest University School of Medicine, Winston-Salem, North Carolina, 2012

Academic Appointments

  • Associate Professor of Radiation Oncology, Mayo Clinic Florida

Hospital/Institution Appointments

  • Senior Associate Consultant, Mayo Clinic Florida

Biographical Statement

Albert Attia, MD, is an Associate Professor and is the Residency Program Director for the Radiation Oncology Department at Mayo Clinic Florida. Prior to his arrival, he was the medical director of Radiation Oncology at St. Francis Cancer Center in Greenville, South Carolina. Prior to that, he was an Associate Professor of Radiation Oncology at Vanderbilt University Medical Center. During his time there, Dr. Attia was the Residency Program Director where he developed the educational program there and mentored many medical students and residents. For his efforts, he was awarded the ARRO Educator of the Year Award. Dr. Attia has served in the past as an American Board of Radiology board examiner. Currently, he is a Director-at-Large on the ADROP Executive Committee. At Mayo, Dr. Attia is the lead radiation oncologist for the genitourinary section and is actively involved in clinical trial development and graduate medical education.